Table of Contents Author Guidelines Submit a Manuscript
International Journal of Vascular Medicine
Volume 2012, Article ID 947417, 11 pages
http://dx.doi.org/10.1155/2012/947417
Review Article

Understanding Postprandial Inflammation and Its Relationship to Lifestyle Behaviour and Metabolic Diseases

1Department of Internal Medicine, Center for Diabetes and Vascular Medicine, Sint Franciscus Gasthuis, 3004 BA Rotterdam, The Netherlands
2Metabolic and Cardiovascular Diseases Lab, Molecular Cell Biology of Lipids Group, Alberta Diabetes and Mazankowski Alberta Heart Institutes, University of Alberta, Edmonton, AB, T6g 2R3, Canada
3Faculty of Health Sciences, Curtin University, Perth and Sydney, WA 6102, Australia
4Department Of Veterinary Basic Sciences, The Royal Veterinary College, London NW1 0TU, UK

Received 23 June 2011; Accepted 29 July 2011

Academic Editor: Karlheinz Peter

Copyright © 2012 Boudewijn Klop et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Braunwald, “Shattuck lecture—cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities,” New England Journal of Medicine, vol. 337, no. 19, pp. 1360–1369, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. C. J. M. Halkes, H. Van Dijk, P. P. T. De Jaegere et al., “Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 9, pp. 1526–1530, 2001. View at Google Scholar · View at Scopus
  3. S. Bansal, J. E. Buring, N. Rifai, S. Mora, F. M. Sacks, and P. M. Ridker, “Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women,” Journal of the American Medical Association, vol. 298, no. 3, pp. 309–316, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Mora, N. Rifai, J. E. Buring, and P. M. Ridker, “Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events,” Circulation, vol. 118, no. 10, pp. 993–1001, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. B. G. Nordestgaard, M. Benn, P. Schnohr, and A. Tybjærg-Hansen, “Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women,” Journal of the American Medical Association, vol. 298, no. 3, pp. 299–308, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Ross, “Atherosclerosis—an inflammatory disease,” New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. A. P. Van Beek, H. H. J. J. Van Barlingen, F. C. De Ruijter-Heijstek et al., “Preferential clearance of apoB-48-containing lipoproteins after heparin- induced lipolysis is modulated by lipoprotein lipase activity,” Journal of Lipid Research, vol. 39, no. 2, pp. 322–332, 1998. View at Google Scholar · View at Scopus
  8. T. G. Redgrave, “Formation and metabolism of chylomicrons,” International review of physiology, vol. 28, pp. 103–130, 1983. View at Google Scholar · View at Scopus
  9. P. Nguyen, V. Leray, M. Diez et al., “Liver lipid metabolism,” Journal of Animal Physiology and Animal Nutrition, vol. 92, no. 3, pp. 272–283, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Castro Cabezas, C. J. M. Halkes, S. Meijssen, A. J. H. H. M. Van Oostrom, and D. W. Erkelens, “Diurnal triglyceride profiles: a novel approach to study triglyceride changes,” Atherosclerosis, vol. 155, no. 1, pp. 219–228, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. J. P. H. Van Wijk, M. Castro Cabezas, C. J. M. Halkes, and D. W. Erkelens, “Effects of different nutrient intakes on daytime triacylglycerolemia in healthy, normolipemic, free-living men,” American Journal of Clinical Nutrition, vol. 74, no. 2, pp. 171–178, 2001. View at Google Scholar · View at Scopus
  12. G. F. Lewis, N. M. O'Meara, P. A. Soltys et al., “Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities,” Journal of Clinical Endocrinology and Metabolism, vol. 72, no. 4, pp. 934–944, 1991. View at Google Scholar · View at Scopus
  13. J. Denis McGarry, “Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes,” Diabetes, vol. 51, no. 1, pp. 7–18, 2002. View at Google Scholar
  14. F. M. Sacks, M. A. Pfeffer, L. A. Moye et al., “The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels,” New England Journal of Medicine, vol. 335, no. 14, pp. 1001–1009, 1996. View at Publisher · View at Google Scholar
  15. J. R. Downs, M. Clearfield, S. Weis et al., “Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS,” Journal of the American Medical Association, vol. 279, no. 20, pp. 1615–1622, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Tonkin, P. Alyward, D. Colquhoun et al., “Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels,” New England Journal of Medicine, vol. 339, no. 19, pp. 1349–1357, 1998. View at Publisher · View at Google Scholar
  17. R. Collins, J. Armitage, S. Parish, P. Sleight, and R. Peto, “MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial,” Lancet, vol. 360, no. 9326, pp. 7–22, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. S. M. Grundy, J. I. Cleeman, C. N. Merz et al., “Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines,” Journal of the American College of Cardiology, vol. 44, no. 3, pp. 720–732, 2004. View at Google Scholar · View at Scopus
  19. M. Castro Cabezas, T. W. A. De Bruin, L. A. W. Kock et al., “Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion,” Metabolism, vol. 42, no. 4, pp. 497–503, 1993. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Castro Cabezas, D. W. Erkelens, L. A. W. Kock, and T. W. A. De Bruin, “Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides,” European Journal of Clinical Investigation, vol. 24, no. 10, pp. 669–678, 1994. View at Google Scholar · View at Scopus
  21. M. Castro Cabezas, C. Verseyden, S. Meijssen, H. Jansen, and D. W. Erkelens, “Effects of atorvastatin on the clearance of triglyceride-rich lipoproteins in familial combined hyperlipidemia,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 12, pp. 5972–5980, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. A. J. H. H. M. Van Oostrom, H. W. M. Plokker, B. S. Van Asbeck et al., “Effects of rosuvastatin on postprandial leukocytes in mildly hyperlipidemic patients with premature coronary sclerosis,” Atherosclerosis, vol. 185, no. 2, pp. 331–339, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Fazio, “Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy,” Clinical Therapeutics, vol. 30, no. 2, pp. 294–306, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Deedwania, P. Barter, R. Carmena et al., “Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study,” Lancet, vol. 368, no. 9539, pp. 919–928, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. J. W. Su, M. M. Ugo Nzekwu, G. D. C. Ball, and S. D. Proctor, “Postprandial lipemia as an early predictor of cardiovascular complications in childhood obesity,” Journal of Clinical Lipidology, vol. 3, no. 2, pp. 78–84, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. J. C. Hogue, B. Lamarche, A. J. Tremblay, J. Bergeron, C. Gagné, and P. Couture, “Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes,” Journal of Lipid Research, vol. 48, no. 6, pp. 1336–1342, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. J. C. L. Mamo and J. R. Wheeler, “Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as do smaller macromolecules, including low-density lipoprotein, high-density lipoprotein, and albumin,” Coronary Artery Disease, vol. 5, no. 8, pp. 695–705, 1994. View at Google Scholar · View at Scopus
  28. K. C. W. Yu and J. C. L. Mamo, “Regulation of cholesterol synthesis and esterification in primary cultures of macrophages following uptake of chylomicron remnants,” Biochemistry and Molecular Biology International, vol. 41, no. 1, pp. 33–39, 1997. View at Google Scholar · View at Scopus
  29. S. Tomono, S. Kawazu, N. Kato et al., “Uptake of remnant like particles (RLP) in diabetic patients from mouse peritoneal macrophages,” Journal of atherosclerosis and thrombosis, vol. 1, no. 2, pp. 98–102, 1994. View at Google Scholar · View at Scopus
  30. K. V. Batt, M. Avella, E. H. Moore, B. Jackson, K. E. Suckling, and K. M. Botham, “Differential effects of low-density lipoprotein and chylomicron remnants on lipid accumulation in human macrophages,” Experimental Biology and Medicine, vol. 229, no. 6, pp. 528–537, 2004. View at Google Scholar · View at Scopus
  31. M. L. Phillips, C. Pullinger, I. Kroes et al., “A single copy of apolipoprotein B-48 is present on the human chylomicron remnant,” Journal of Lipid Research, vol. 38, no. 6, pp. 1170–1177, 1997. View at Google Scholar · View at Scopus
  32. J. C. L. Mamo, G. F. Watts, P. H. R. Barrett, D. Smith, A. P. James, and P. A. L. Sebely, “Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?” American Journal of Physiology, vol. 281, no. 3, pp. E626–E632, 2001. View at Google Scholar · View at Scopus
  33. C. Phillips, G. Murugasu, D. Owens, P. Collins, A. Johnson, and G. H. Tomkin, “Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in Type 2 diabetes,” Atherosclerosis, vol. 148, no. 2, pp. 283–291, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. D. C. Chan, G. F. Watts, P. H. Barrett, J. C. L. Mamo, and T. G. Redgrave, “Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity,” Clinical Chemistry, vol. 48, no. 2, pp. 278–283, 2002. View at Google Scholar · View at Scopus
  35. J. S. Cohn, C. Marcoux, and J. Davignon, “Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 10, pp. 2474–2486, 1999. View at Google Scholar · View at Scopus
  36. M. Castro Cabezas and D. W. Erkelens, “The direct way from gut to vessel wall: atheroinitiation,” European Journal of Clinical Investigation, vol. 28, no. 6, pp. 504–505, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. C. A. Dane-Stewart, G. F. Watts, J. C. L. Mamo, S. B. Dimmitt, P. H. R. Barrett, and T. G. Redgrave, “Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemia,” European Journal of Clinical Investigation, vol. 31, no. 2, pp. 113–117, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. G. F. Watts, P. H. R. Barrett, A. D. Marais et al., “Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test,” Atherosclerosis, vol. 157, no. 2, pp. 519–523, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. S. D. Proctor, D. F. Vine, and J. C. L. Mamo, “Arterial retention of apolipoprotein B48- and B100-containing lipoproteins in atherogenesis,” Current Opinion in Lipidology, vol. 13, no. 5, pp. 461–470, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. S. D. Proctor, D. F. Vine, and J. C. L. Mamo, “Arterial permeability and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 11, pp. 2162–2167, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. I. J. Goldberg, R. H. Eckel, and R. McPherson, “Triglycerides and heart disease: still a hypothesis?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 8, pp. 1716–1725, 2011. View at Publisher · View at Google Scholar
  42. N. J. Abbott, A. A. K. Patabendige, D. E. M. Dolman, S. R. Yusof, and D. J. Begley, “Structure and function of the blood-brain barrier,” Neurobiology of Disease, vol. 37, no. 1, pp. 13–25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. K. C. Yu and A. D. Cooper, “Postprandial lipoproteins and atherosclerosis,” Front Biosci, vol. 6, pp. D332–D354, 2001. View at Google Scholar · View at Scopus
  44. J. E. Schaffer, “Lipotoxicity: when tissues overeat,” Current Opinion in Lipidology, vol. 14, no. 3, pp. 281–287, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Ronti, G. Lupattelli, and E. Mannarino, “The endocrine function of adipose tissue: an update,” Clinical Endocrinology, vol. 64, no. 4, pp. 355–365, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. R. H. Unger, “Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications,” Diabetes, vol. 44, no. 8, pp. 863–870, 1995. View at Google Scholar · View at Scopus
  47. P. M. Yao and I. Tabas, “Free cholesterol loading of macrophages is associated with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway,” Journal of Biological Chemistry, vol. 276, no. 45, pp. 42468–42476, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Laplante and D. M. Sabatini, “An emerging role of mTOR in lipid biosynthesis,” Current Biology, vol. 19, no. 22, pp. R1046–R1052, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. B. Mackness, R. Quarck, W. Verreth, M. Mackness, and P. Holvoet, “Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 7, pp. 1545–1550, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Vaisar, S. Pennathur, P. S. Green et al., “Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL,” Journal of Clinical Investigation, vol. 117, no. 3, pp. 746–756, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. L. R. Tannock and A. Chait, “Lipoprotein-matrix interactions in macrovascular disease in diabetes,” Frontiers in Bioscience, vol. 9, pp. 1728–1742, 2004. View at Google Scholar · View at Scopus
  52. K. M. Botham, E. H. Moore, C. De Pascale, and F. Bejta, “The induction of macrophage foam cell formation by chylomicron remnants,” Biochemical Society Transactions, vol. 35, no. 3, pp. 454–458, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. C. De Pascale, M. Avella, J. S. Perona, V. Ruiz-Gutierrez, C. P. D. Wheeler-Jones, and K. M. Botham, “Fatty acid composition of chylomicron remnant-like particles influences their uptake and induction of lipid accumulation in macrophages,” FEBS Journal, vol. 273, no. 24, pp. 5632–5640, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. A. M. Lefer, “Nitric oxide: nature's naturally occurring leukocyte inhibitor,” Circulation, vol. 95, no. 3, pp. 553–554, 1997. View at Google Scholar · View at Scopus
  55. J. Dalla-Riva, E. Garonna, J. Elliott, K. M. Botham, and C. P. Wheeler-Jones, “Endothelial cells as targets for chylomicron remnants,” Atherosclerosis Supplements, vol. 11, no. 1, pp. 31–37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Boquist, G. Ruotolo, R. Tang et al., “Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men,” Circulation, vol. 100, no. 7, pp. 723–728, 1999. View at Google Scholar · View at Scopus
  57. S. Marchesi, G. Lupattelli, G. Schillaci et al., “Impaired flow-mediated vasoactivity during post-prandial phase in young healthy men,” Atherosclerosis, vol. 153, no. 2, pp. 397–402, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. R. A. Vogel, M. C. Corretti, and G. D. Plotnick, “Effect of a single high-fat meal on endothelial function in healthy subjects,” American Journal of Cardiology, vol. 79, no. 3, pp. 350–354, 1997. View at Publisher · View at Google Scholar · View at Scopus
  59. P. J. Lefèbvre and A. J. Scheen, “The postprandial state and risk of cardiovascular disease,” Diabetic Medicine, vol. 15, no. 4, pp. S63–S68, 1998. View at Google Scholar · View at Scopus
  60. C. P. D. Wheeler-Jones, “Chylomicron remnants: mediators of endothelial dysfunction?” Biochemical Society Transactions, vol. 35, no. 3, pp. 442–445, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Danesh, P. Whincup, M. Walker et al., “Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses,” British Medical Journal, vol. 321, no. 7255, pp. 199–204, 2000. View at Google Scholar · View at Scopus
  62. G. D. Friedman, A. L. Klatsky, and A. B. Siegelaub, “The leukocyte count as a predictor of myocardial infarction,” New England Journal of Medicine, vol. 290, no. 23, pp. 1275–1278, 1974. View at Google Scholar · View at Scopus
  63. S. Meijssen, H. Van Dijk, C. Verseyden, D. W. Erkelens, and M. Castro Cabezas, “Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 5, pp. 811–816, 2002. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Muscari, G. Massarelli, L. Bastagli et al., “Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men,” European Heart Journal, vol. 21, no. 13, pp. 1081–1090, 2000. View at Publisher · View at Google Scholar · View at Scopus
  65. M. I. Schmidt, B. B. Duncan, A. R. Sharrett et al., “Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study,” Lancet, vol. 353, no. 9165, pp. 1649–1652, 1999. View at Publisher · View at Google Scholar · View at Scopus
  66. C. Verseyden, S. Meijssen, H. Van Dijk, H. Jansen, and M. Castro Cabezas, “Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia,” Journal of Lipid Research, vol. 44, no. 11, pp. 2100–2108, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. E. E. Eriksson, X. Xie, J. Werr, P. Thoren, and L. Lindbom, “Direct viewing of atherosclerosis in vivo: plaque invasion by leukocytes is initiated by the endothelial selectins,” FASEB Journal, vol. 15, no. 7, pp. 1149–1157, 2001. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. Huo and K. Ley, “Adhesion molecules and atherogenesis,” Acta Physiologica Scandinavica, vol. 173, no. 1, pp. 35–43, 2001. View at Publisher · View at Google Scholar · View at Scopus
  69. T. Murohara, M. Buerke, and A. M. Lefer, “Polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction: role of selectins,” Arteriosclerosis and Thrombosis, vol. 14, no. 9, pp. 1509–1519, 1994. View at Google Scholar · View at Scopus
  70. R. A. Worthylake and K. Burridge, “Leukocyte transendothelial migration: orchestrating the underlying molecular machinery,” Current Opinion in Cell Biology, vol. 13, no. 5, pp. 569–577, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. A. J. H. H. M. Van Oostrom, T. P. Sijmonsma, T. J. Rabelink, B. S. Van Asbeck, and M. Castro Cabezas, “Postprandial leukocyte increase in healthy subjects,” Metabolism, vol. 52, no. 2, pp. 199–202, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. A. J. H. H. M. Van Oostrom, T. P. Sijmonsma, C. Verseyden et al., “Postprandial recruitment of neutrophils may contribute to endothelial dysfunction,” Journal of Lipid Research, vol. 44, no. 3, pp. 576–583, 2003. View at Publisher · View at Google Scholar · View at Scopus
  73. G. Wanten, S. Van Emst-de Vries, T. Naber, and P. Willems, “Nutritional lipid emulsions modulate cellular signaling and activation of human neutrophils,” Journal of Lipid Research, vol. 42, no. 3, pp. 428–436, 2001. View at Google Scholar · View at Scopus
  74. C. Bentley, N. Hathaway, J. Widdows et al., “Influence of chylomicron remnants on human monocyte activation in vitro,” Nutrition, Metabolism and Cardiovascular Diseases. In press. View at Publisher · View at Google Scholar · View at Scopus
  75. K. Hiramatsu and S. Arimori, “Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes,” Diabetes, vol. 37, no. 6, pp. 832–837, 1988. View at Google Scholar · View at Scopus
  76. A. J. H. H. M. Van Oostrom, T. J. Rabelink, C. Verseyden et al., “Activation of leukocytes by postprandial lipemia in healthy volunteers,” Atherosclerosis, vol. 177, no. 1, pp. 175–182, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. V. V. Tertov, O. S. Kalenich, and A. N. Orekhov, “Lipid-laden white blood cells in the circulation of patients with coronary heart disease,” Experimental and Molecular Pathology, vol. 57, no. 1, pp. 22–28, 1992. View at Publisher · View at Google Scholar · View at Scopus
  78. B. Skrede, R. Blomhoff, G. M. Maelandsmo, L. Ose, O. Myklebost, and K. R. Norum, “Uptake of chylomicron remnant retinyl esters in human leukocytes in vivo,” European Journal of Clinical Investigation, vol. 22, no. 4, pp. 229–234, 1992. View at Google Scholar · View at Scopus
  79. A. Alipour, A. J. H. H. M. Van Oostrom, A. Izraeljan et al., “Leukocyte activation by triglyceride-rich lipoproteins,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 4, pp. 792–797, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. K. Cianflone, Z. Xia, and L. Y. Chen, “Critical review of acylation-stimulating protein physiology in humans and rodents,” Biochimica et Biophysica Acta, vol. 1609, no. 2, pp. 127–143, 2003. View at Publisher · View at Google Scholar · View at Scopus
  81. A. J. H. H. M. van Oostrom, A. Alipour, T. W. M. Plokker, A. D. Sniderman, and M. Castro Cabezas, “The metabolic syndrome in relation to complement component 3 and postprandial lipemia in patients from an outpatient lipid clinic and healthy volunteers,” Atherosclerosis, vol. 190, no. 1, pp. 167–173, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. J. Torzewski, M. Torzewski, D. E. Bowyer et al., “C-Reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 18, no. 9, pp. 1386–1392, 1998. View at Google Scholar · View at Scopus
  83. M. Griselli, J. Herbert, W. L. Hutchinson et al., “C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction,” Journal of Experimental Medicine, vol. 190, no. 12, pp. 1733–1739, 1999. View at Publisher · View at Google Scholar · View at Scopus
  84. T. Scantlebury, A. D. Sniderman, and K. Cianflone, “Regulation by retinoic acid of acylation-stimulating protein and complement C3 in human adipocytes,” Biochemical Journal, vol. 356, no. 2, pp. 445–452, 2001. View at Publisher · View at Google Scholar · View at Scopus
  85. C. J. M. Halkes, H. Van Dijk, C. Verseyden et al., “Gender differences in postprandial ketone bodies in normolipidemic subjects and in untreated patients with familial combined hyperlipidemia,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 10, pp. 1875–1880, 2003. View at Publisher · View at Google Scholar · View at Scopus
  86. M. Laakso, “Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West award lecture 2008,” Diabetes Care, vol. 33, no. 2, pp. 442–449, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. M. Laakso, “Insulin resistance and coronary heart disease,” Current Opinion in Lipidology, vol. 7, no. 4, pp. 217–226, 1996. View at Google Scholar · View at Scopus
  88. J. B. Ruige, W. J. J. Assendelft, J. M. Dekker, P. J. Kostense, R. J. Heine, and L. M. Bouter, “Insulin and risk of cardiovascular disease: a meta-analysis,” Circulation, vol. 97, no. 10, pp. 996–1001, 1998. View at Google Scholar · View at Scopus
  89. S. Mottillo, K. B. Filion, J. Genest et al., “The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis,” Journal of the American College of Cardiology, vol. 56, no. 14, pp. 1113–1132, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. C. M. Alexander, P. B. Landsman, S. M. Teutsch, and S. M. Haffner, “NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older,” Diabetes, vol. 52, no. 5, pp. 1210–1214, 2003. View at Publisher · View at Google Scholar · View at Scopus
  91. J. Koskinen, M. Kähönen, J. S. A. Viikari et al., “Conventional cardiovascular risk factors and metabolic syndrome in predicting carotid intima-media thickness progression in young adults: the cardiovascular risk in young finns study,” Circulation, vol. 120, no. 3, pp. 229–236, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. D. E. Moller and K. D. Kaufman, “Metabolic syndrome: a clinical and molecular perspective,” Annual Review of Medicine, vol. 56, pp. 45–62, 2005. View at Publisher · View at Google Scholar · View at Scopus
  93. R. H. Eckel, S. M. Grundy, and P. Z. Zimmet, “The metabolic syndrome,” Lancet, vol. 365, no. 9468, pp. 1415–1428, 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. K. G. M. M. Alberti, P. Zimmet, and J. Shaw, “The metabolic syndrome—a new worldwide definition,” Lancet, vol. 366, no. 9491, pp. 1059–1062, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. D. R. Sullivan, D. S. Celermajer, D. G. Le Couteur, and C. W. Lam, “The vascular implications of post-prandial lipoprotein metabolism,” Clinical Biochemistry Reviews, vol. 25, no. 1, pp. 19–30, 2004. View at Google Scholar
  96. J. Lopez-Miranda, C. Williams, and D. Larion, “Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism,” British Journal of Nutrition, vol. 98, no. 3, pp. 458–473, 2007. View at Publisher · View at Google Scholar · View at Scopus
  97. D. Lairon and C. Defoort, “Effects of nutrients on postprandial lipemia,” Current Vascular Pharmacology, vol. 9, no. 3, pp. 309–312, 2011. View at Publisher · View at Google Scholar
  98. E. Bravo, M. Napolitano, and K. M. Botham, “Postprandial lipid metabolism: the missing link between life-style habits and the increasing incidence of metabolic diseases in western countries?” Open Translational Medicine Journal, vol. 2, pp. 1–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. C. Dubois, G. Beaumier, C. Juhel et al., “Effects of graded amounts (0–50 g) of dietary fat on postprandial lipemia and lipoproteins in normolipidemic adults,” American Journal of Clinical Nutrition, vol. 67, no. 1, pp. 31–38, 1998. View at Google Scholar · View at Scopus
  100. A. R. Sharrett, G. Heiss, L. E. Chambless et al., “Metabolic and lifestyle determinants of postprandial lipemia differ from those of fasting triglycerides the Atherosclerosis Risk in Communities (ARIC) study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 2, pp. 275–281, 2001. View at Google Scholar · View at Scopus
  101. D. Lairon, B. Play, and D. Jourdheuil-Rahmani, “Digestible and indigestible carbohydrates: interactions with postprandial lipid metabolism,” Journal of Nutritional Biochemistry, vol. 18, no. 4, pp. 217–227, 2007. View at Publisher · View at Google Scholar · View at Scopus
  102. A. Zampelas, A. S. Peel, B. J. Gould, J. Wright, and C. M. Williams, “Polyunsaturated fatty acids of the n-6 and n-3 series: effects on postprandial lipid and apolipoprotein levels in healthy men,” European Journal of Clinical Nutrition, vol. 48, no. 12, pp. 842–848, 1994. View at Google Scholar · View at Scopus
  103. C. M. Williams, F. Moore, L. Morgan, and J. Wright, “Effects of n-3 fatty acids on postprandial triacylglycerol and hormone concentrations in normal subjects,” British Journal of Nutrition, vol. 68, no. 3, pp. 655–666, 1992. View at Publisher · View at Google Scholar · View at Scopus
  104. W. S. Harris and F. Muzio, “Fish oil reduces postprandial triglyceride concentrations without accelerating lipid-emulsion removal rates,” American Journal of Clinical Nutrition, vol. 58, no. 1, pp. 68–74, 1993. View at Google Scholar · View at Scopus
  105. D. S. Kelley, D. Siegel, M. Vemuri, and B. E. Mackey, “Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men,” American Journal of Clinical Nutrition, vol. 86, no. 2, pp. 324–333, 2007. View at Google Scholar · View at Scopus
  106. S. Westphal, M. Orth, A. Ambrosch, K. Osmundsen, and C. Luley, “Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acids,” American Journal of Clinical Nutrition, vol. 71, no. 4, pp. 914–920, 2000. View at Google Scholar · View at Scopus
  107. D. Lairon, “Macronutrient intake and modulation on chylomicron production and clearance,” Atherosclerosis Supplements, vol. 9, no. 2, pp. 45–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  108. A. Lozano, P. Perez-Martinez, J. Delgado-Lista et al., “Body mass interacts with fat quality to determine the postprandial lipoprotein response in healthy young adults,” Nutrition, Metabolism and Cardiovascular Disease. In press.
  109. L. S. Mortensen, M. L. Hartvigsen, L. J. Brader et al., “Differential effects of protein quality on postprandial lipemia in response to a fat-rich meal in type 2 diabetes: comparison of whey, casein, gluten, and cod protein,” American Journal of Clinical Nutrition, vol. 90, no. 1, pp. 41–48, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. A. Khossousi, C. W. Binns, S. S. Dhaliwal, and S. Pal, “The acute effects of psyllium on postprandial lipaemia and thermogenesis in overweight and obese men,” British Journal of Nutrition, vol. 99, no. 5, pp. 1068–1075, 2008. View at Publisher · View at Google Scholar · View at Scopus
  111. A. Harbis, S. Perdreau, S. Vincent-Baudry et al., “Glycemic and insulinemic meal responses modulate postprandial hepatic and intestinal lipoprotein accumulation in obese, insulin-resistant subjects,” American Journal of Clinical Nutrition, vol. 80, no. 4, pp. 896–902, 2004. View at Google Scholar · View at Scopus
  112. G. Livesey and R. Taylor, “Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies,” American Journal of Clinical Nutrition, vol. 88, no. 5, pp. 1419–1437, 2008. View at Publisher · View at Google Scholar · View at Scopus
  113. A. Mente, L. De Koning, H. S. Shannon, and S. S. Anand, “A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease,” Archives of Internal Medicine, vol. 169, no. 7, pp. 659–669, 2009. View at Publisher · View at Google Scholar · View at Scopus
  114. A. Basu and E. A. Lucas, “Mechanisms and effects of green tea on cardiovascular health,” Nutrition Reviews, vol. 65, no. 8, pp. 361–375, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. B. Burton-Freeman, A. Linares, D. Hyson, and T. Kappagoda, “Strawberry modulates LDL oxidation and postprandial lipemia in response to high-fat meal in overweight hyperlipidemic men and women,” Journal of the American College of Nutrition, vol. 29, no. 1, pp. 46–54, 2010. View at Google Scholar · View at Scopus
  116. R. Abia, Y. M. Pacheco, J. S. Perona, E. Montero, F. J. G. Muriana, and V. Ruiz-Gutiérrez, “The metabolic availability of dietary triacylglycerols from two high oleic oils during the postprandial period does not depend on the amount of oleic acid ingested by healthy men,” Journal of Nutrition, vol. 131, no. 1, pp. 59–65, 2001. View at Google Scholar · View at Scopus
  117. M. Castro Cabezas, J. H. M. de Vries, A. J. H. H. M. Van Oostrom, J. Iestra, and W. A. van Staveren, “Effects of a stanol-enriched diet on plasma cholesterol and triglycerides in patients treated with statins,” Journal of the American Dietetic Association, vol. 106, no. 10, pp. 1564–1569, 2006. View at Publisher · View at Google Scholar · View at Scopus
  118. L. T. Braun, “Cholesterol and triglyceride management: “If i take my medication, can I Eat what I Want?”,” Journal of Cardiovascular Nursing, vol. 25, no. 3, pp. 241–246, 2010. View at Publisher · View at Google Scholar · View at Scopus
  119. M. Maraki, F. Magkos, N. Christodoulou et al., “One day of moderate energy deficit reduces fasting and postprandial triacylglycerolemia in women: the role of calorie restriction and exercise,” Clinical Nutrition, vol. 29, no. 4, pp. 459–463, 2010. View at Publisher · View at Google Scholar · View at Scopus
  120. M. I. Maraki, N. Aggelopoulou, N. Christodoulou et al., “Lifestyle intervention leading to moderate weight loss normalizes postprandial triacylglycerolemia despite persisting obesity,” Obesity, vol. 19, no. 5, pp. 968–976, 2011. View at Publisher · View at Google Scholar
  121. O. J. MacEneaney, M. Harrison, D. J. O'Gorman, E. V. Pankratieva, P. L. O'Connor, and N. M. Moyna, “Effect of prior exercise on postprandial lipemia and markers of inflammation and endothelial activation in normal weight and overweight adolescent boys,” European Journal of Applied Physiology, vol. 106, no. 5, pp. 721–729, 2009. View at Publisher · View at Google Scholar · View at Scopus
  122. Z. K. Pafili, G. C. Bogdanis, N. V. Tsetsonis, and M. Maridaki, “Postprandial lipemia 16 and 40 hours after low-volume eccentric resistance exercise,” Medicine and Science in Sports and Exercise, vol. 41, no. 2, pp. 375–382, 2009. View at Publisher · View at Google Scholar · View at Scopus
  123. M. J. Dekker, T. E. Graham, T. C. Ooi, and L. E. Robinson, “Exercise prior to fat ingestion lowers fasting and postprandial VLDL and decreases adipose tissue IL-6 and GIP receptor mRNA in hypertriacylglycerolemic men,” Journal of Nutritional Biochemistry, vol. 21, no. 10, pp. 983–990, 2010. View at Publisher · View at Google Scholar · View at Scopus
  124. M. Miyashita, S. F. Burns, and D. J. Stensel, “Acute effects of accumulating exercise on postprandial lipemia and C-reactive protein concentrations in young men,” International Journal of Sport Nutrition and Exercise Metabolism, vol. 19, no. 6, pp. 569–582, 2009. View at Google Scholar · View at Scopus
  125. C. Gavin, R. J. Sigal, M. Cousins et al., “Resistance exercise but not aerobic exercise lowers remnant-like lipoprotein particle cholesterol in type 2 diabetes: a randomized controlled trial,” Atherosclerosis, vol. 213, no. 2, pp. 552–557, 2010. View at Publisher · View at Google Scholar · View at Scopus
  126. A. Singhal, J. L. Trilk, N. T. Jenkins, K. A. Bigelman, and K. J. Cureton, “Effect of intensity of resistance exercise on postprandial lipemia,” Journal of Applied Physiology, vol. 106, no. 3, pp. 823–829, 2009. View at Publisher · View at Google Scholar · View at Scopus
  127. M. H. Murphy, S. N. Blair, and E. M. Murtagh, “Accumulated versus continuous exercise for health benefit: a review of empirical studies,” Sports Medicine, vol. 39, no. 1, pp. 29–43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  128. R. J. Bloomer and K. H. Fisher-Wellman, “Postprandial oxidative stress in exercise trained and sedentary cigarette smokers,” International Journal of Environmental Research and Public Health, vol. 6, no. 2, pp. 579–591, 2009. View at Publisher · View at Google Scholar · View at Scopus
  129. R. J. Bloomer, K. H. Fisher-Wellman, and H. K. Bell, “The effect of long-term, high-volume aerobic exercise training on postprandial lipemia and oxidative stress,” Physician and Sportsmedicine, vol. 38, no. 1, pp. 64–71, 2010. View at Publisher · View at Google Scholar · View at Scopus
  130. J. H. O'Keefe, N. M. Gheewala, and J. O. O'Keefe, “Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health,” Journal of the American College of Cardiology, vol. 51, no. 3, pp. 249–255, 2008. View at Publisher · View at Google Scholar · View at Scopus
  131. M. Naissides, J. C. L. Mamo, A. P. James, and S. Pal, “The effect of acute red wine polyphenol consumption on postprandial lipaemia in postmenopausal women,” Atherosclerosis, vol. 177, no. 2, pp. 401–408, 2004. View at Publisher · View at Google Scholar · View at Scopus
  132. N. Mero, M. Syvanne, B. Eliasson, U. Smith, and M. R. Taskinen, “Postprandial elevation of apoB-48-containing triglyceride-rich particles and retinyl esters in normolipemic males who smoke,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 10, pp. 2096–2102, 1997. View at Google Scholar · View at Scopus
  133. S. Meijssen, R. J. Derksen, S. Bilecen, D. W. Erkelens, and M. Castro Cabezas, “In vivo modulation of plasma free fatty acids in patients with Familial Combined Hyperlipidemia using Lipid-Lowering medication,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 4, pp. 1576–1580, 2002. View at Publisher · View at Google Scholar · View at Scopus
  134. E. S. Ford, C. Li, G. Zhao, W. S. Pearson, and A. H. Mokdad, “Hypertrigly ceridemia and Its pharmacologic treatment among US adults,” Archives of Internal Medicine, vol. 169, no. 6, pp. 572–578, 2009. View at Publisher · View at Google Scholar · View at Scopus
  135. M. Jun, C. Foote, J. Lv et al., “Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis,” The Lancet, vol. 375, no. 9729, pp. 1875–1884, 2010. View at Publisher · View at Google Scholar · View at Scopus
  136. J. P. H. Van Wijk, A. I. M. Hoepelman, E. J. P. De Koning, G. Dallinga-Thie, T. J. Rabelink, and M. Castro Cabezas, “Differential effects of rosiglitazone and metformin on postprandial lipemia in patients with HIV-lipodystrophy,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 1, pp. 228–233, 2011. View at Publisher · View at Google Scholar · View at Scopus